Rare Metastases Detected by 68Ga-Somatostatin Receptor PET/CT in Patients with Neuroendocrine Tumors

  • Cecilia Carreras
  • Harshad R. Kulkarni
  • Richard P. Baum
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 194)


Aim: The most common sites of metastasis in neuroendocrine tumors are liver, lymph nodes, and bone. The aim of this study is to determine the prevalence and location of other sites of metastasis. Methods: 4,210 Ga-68 somatostatin-receptor PET/CT studies were performed at our center between July 2004 and December 2009. We retrospectively reviewed the reports of patients to check rare sites of metastasis other than liver, bone, and lymph nodes. Lesions were confirmed on follow-up and/or other imaging methods (MRI, echocardiography, and ultrasound). Results: The different sites of metastasis according to frequency of occurrence were: cardiac (n = 29), breast (n = 21), retro-orbital (n = 9), uterus (n = 7), skin (n = 8), brain (n = 6), spleen (n = 3), testes (n = 1), seminal vesicle (n = 1), and intramuscular in psoas muscle (n = 4). Conclusions: Cardiac and breast metastases appear to be not infrequent in neuroendocrine tumor patients. Ga-68 somatostatin-receptor PET/CT enables detection of these and other rare sites of metastasis.


Neuroendocrine Tumor Seminal Vesicle Carcinoid Tumor Rare Site Breast Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Balmforth D, Skouras C, Palazzo F, Zacharakis E (2011) Laparoscopic management for carcinoid metastasis to the spleen. HPB Surg 2011(346507):4Google Scholar
  2. Bussani R, De-Giorgio F, Abbate A, Silvestri F (2007) Cardiac metastases. J Clin Pathol 60(1):27–34PubMedCrossRefGoogle Scholar
  3. Geyer HL, Viney J, Karlin N (2010) Metastatic carcinoid presenting as a breast lesion. Curr Oncol 17(6):73–77PubMedCrossRefGoogle Scholar
  4. Isidori AM, Kaltsas G, Frajese V, Kola B, Whitelocke RA, Plowman PN, Britton KE, Monson JP, Grossman AB, Besser GM (2002) Ocular metastases secondary to carcinoid tumors: the utility of imaging with 123I-MIBG and 111In-DTPA pentetreotide. J Clin Endocrinol Metab 87:1627–1633PubMedCrossRefGoogle Scholar
  5. Makhija Z, Deshpande R, Desai J (2009) Unusual tumors of the heart: diagnostic and prognostic implications. J Cardiothorac Surg 4:4PubMedCrossRefGoogle Scholar
  6. Rafajlovski S, Tatić V, Ilić S, Kanjuh V (2005) Frequency of metastatic tumors in the heart. Vojnosanit Pregl 62(12):915–920PubMedCrossRefGoogle Scholar
  7. Smith C (1986) Tumors of the heart. Arch 110(5):371–374Google Scholar
  8. Scarsbrook AF, Ganeshan A, Statham J, Thakker RV, Weaver A, Talbot D, Boardman P, Bradley KM, Gleeson FV, Phillips RR (2007) Anatomic and functional imaging of metastatic carcinoid tumors. Radio Graphics 27:455–477Google Scholar
  9. Srirajaskanthan R, Desai K, Jayaratnam A, Carras E, Toumpanakis C, Meyer T, Caplin M (2009) Uncommon sites for metastasis of neuroendocrine tumor in adults. J Clin Oncol 27:4656Google Scholar
  10. Zuetenhorst JM, Taal BG (2005) Metastatic carcinoid tumors: a clinical review. Oncologist 10:123–131PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Cecilia Carreras
    • 1
  • Harshad R. Kulkarni
    • 1
  • Richard P. Baum
    • 1
  1. 1.Department of Nuclear Medicine/Center for PET/CTENETS Center of Excellence, Zentralklinik Bad BerkaBad BerkaGermany

Personalised recommendations